Zelnorm (also Zelmac) is the brand name for the pharmaceutical product Tegaserod, marketed by Novartis as a remedy for irritable bowel syndrome (IBS) and constipation. Zelnorm was introduced to the U.S. market in 2002, subsequent to Food and Drug Administration (FDA) approval.
In 2007, the FDA asked Novartis to take Zelnorm off the market, based on an analysis of data by the agency. After receiving reports that Zelnorm might be tied to increased risk of stroke or heart attack, the FDA reviewed data from more than 18,000 patients. The study showed that the incidences of cardiovascular problems of people who took Zelnorm was more than 10 times the rate of those who took a placebo.
If you or someone you love has suffered injury after being prescribed Zelnorm, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
Rethinking Marijuana-Related Crimes
In recent years, the way we have thought about marijuana, its use and its legality, have changed. Me…Read More 11 Feb 2019, Monday
What You Need to Know about Flood Insurance
In the past few years, cities have been battered by hurricanes and tropical storms, resulting in inj…Read More 04 Feb 2019, Monday
Three Common Types of Temporary Visas
With all the controversy swirling around immigration these days, you’ve probably heard discussions…Read More 28 Jan 2019, Monday